# EDGAR Filing Document

**Accession Number:** 0001794783
**File Stem:** 0001794783-25-000062
**Filing Date:** 2025-8
**Character Count:** 13403
**Document Hash:** 0a0253b281d9db2d93d9bf8f8a127ec4
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001794783-25-000062.hdr.sgml**: 20250805

**ACCESSION NUMBER**: 0001794783-25-000062

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20250801

**FILED AS OF DATE**: 20250805

**DATE AS OF CHANGE**: 20250805

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Grant Robert Clay
- **CENTRAL INDEX KEY:** 0001804765

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-39295
- **FILM NUMBER:** 251187022

**MAIL ADDRESS:**
- **STREET 1:** 6800 W 115TH STREET
- **STREET 2:** SUITE 2511
- **CITY:** PARK
- **STATE:** KS
- **ZIP:** 66211
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** SelectQuote, Inc.
- **CENTRAL INDEX KEY:** 0001794783
- **STANDARD INDUSTRIAL CLASSIFICATION:** INSURANCE AGENTS BROKERS & SERVICES [6411]
- **ORGANIZATION NAME:** 02 Finance
- **EIN:** 943339273
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0630

**BUSINESS ADDRESS:**
- **STREET 1:** 6800 WEST 115TH STREET
- **STREET 2:** SUITE 2511
- **CITY:** OVERLAND PARK
- **STATE:** KS
- **ZIP:** 66211
- **BUSINESS PHONE:** 9132741994

**MAIL ADDRESS:**
- **STREET 1:** 6800 WEST 115TH STREET
- **STREET 2:** SUITE 2511
- **CITY:** OVERLAND PARK
- **STATE:** KS
- **ZIP:** 66211

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Grant Robert Clay<br><sub>(Last) (First) (Middle)</sub><br>C/O SELECTQUOTE, INC.<br>6800 WEST 115TH STREET, SUITE 2511<br><sub>(Street)</sub><br>OVERLAND PARK, KS 66211<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2025-08-01 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [ ] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_PRESIDENT_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>SelectQuote, Inc. [ SLQT ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Common Stock, par value $0.01 per share | 2025-08-01 |  | M |  | 10804 | A | $0 | 2475212 | D |  |
| Common Stock, par value $0.01 per share | 2025-08-01 |  | M |  | 105602 | A | $0 | 2580814 | D |  |
| Common Stock, par value $0.01 per share | 2025-08-01 |  | M |  | 255555 | A | $0 | 2836369 | D |  |
| Common Stock, par value $0.01 per share | 2025-08-01 |  | M |  | 122470 | A | $0 | 2958839 | D |  |
| Common Stock, par value $0.01 per share | 2025-08-01 |  | M |  | 63889 | A | $0 | 3022728 | D |  |
| Common Stock, par value $0.01 per share | 2025-08-01 |  | M |  | 31945 | A | $0 | 3054673 | D |  |
| Common Stock, par value $0.01 per share | 2025-08-01 |  | M |  | 40824 | A | $0 | 3095497 | D |  |
| Common Stock, par value $0.01 per share | 2025-08-02 |  | F |  | 204163<sup>(1)</sup> | D | $1.74 | 2891334 | D |  |
| Common Stock, par value $0.01 per share |  |  |  |  |  |  |  | 1242000 | I | By Self as Trustee for the Robert Clay Grant Irrevocable Trust |
| Common Stock, par value $0.01 per share |  |  |  |  |  |  |  | 61400 | I | By G. Grant Irrevocable Trust<sup>(2)</sup> |
| Common Stock, par value $0.01 per share |  |  |  |  |  |  |  | 61400 | I | By A. Grant Irrevocable Trust<sup>(2)</sup> |
| Common Stock, par value $0.01 per share |  |  |  |  |  |  |  | 61400 | I | By R. Grant Irrevocable Trust<sup>(2)</sup> |
| Common Stock, par value $0.01 per share |  |  |  |  |  |  |  | 1089369 | I | By Haakon Capital, LLC<sup>(3)</sup> |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Restricted Stock Units<sup>(4)</sup> | <sup>(5)</sup> | 2025-08-01 |  | M |  |  | 10804 | <sup>(6)</sup> | 2031-08-01 | Common Stock, par value $0.01 per share | 10804 | <sup>(5)</sup> | 0 | D |  |
| Restricted Stock Units<sup>(4)</sup> | <sup>(5)</sup> | 2025-08-01 |  | M |  |  | 105602 | <sup>(7)</sup> | 2032-08-01 | Common Stock, par value $0.01 per share | 105602 | <sup>(5)</sup> | 0 | D |  |
| Restricted Stock Units<sup>(4)</sup> | <sup>(5)</sup> | 2025-08-01 |  | M |  |  | 255555 | <sup>(8)</sup> | 2033-09-13 | Common Stock, par value $0.01 per share | 255555 | <sup>(5)</sup> | 255557 | D |  |
| Restricted Stock Units<sup>(4)</sup> | <sup>(5)</sup> | 2025-08-01 |  | M |  |  | 122470 | <sup>(9)</sup> | 2034-10-28 | Common Stock, par value $0.01 per share | 122470 | <sup>(5)</sup> | 244942 | D |  |
| Price-Vested Restricted Stock Units<sup>(10)</sup> | <sup>(11)</sup> | 2025-08-01 |  | M |  |  | 63889 | <sup>(12)</sup> | 2027-08-01 | Common Stock, par value $0.01 per share | 63889 | <sup>(11)</sup> | 574999 | D |  |
| Price-Vested Restricted Stock Units<sup>(10)</sup> | <sup>(11)</sup> | 2025-08-01 |  | M |  |  | 31945 | <sup>(13)</sup> | 2028-08-01 | Common Stock, par value $0.01 per share | 31945 | <sup>(11)</sup> | 319444 | D |  |
| Price-Vested Restricted Stock Units<sup>(10)</sup> | <sup>(11)</sup> | 2025-08-01 |  | M |  |  | 40824 | <sup>(14)</sup> | 2029-10-28 | Common Stock, par value $0.01 per share | 40824 | <sup>(11)</sup> | 326588 | D |  |
| Restricted Stock Units<sup>(4)</sup> | <sup>(5)</sup> | 2025-08-01 |  | A |  | 460000 |  | <sup>(7)</sup> | 2035-08-01 | Common Stock, par value $0.01 per share | 460000 | <sup>(5)</sup> | 460000 | D |  |
| Price-Vested Restricted Stock Units<sup>(10)</sup> | <sup>(11)</sup> | 2025-08-01 |  | A |  | 460000 |  | <sup>(15)</sup> | 2030-08-01 | Common Stock, par value $0.01 per share | 460000 | <sup>(11)</sup> | 460000 | D |  |

---

### Footnotes:

(1) Represents shares surrendered to the issuer to satisfy withholding taxes owed upon the vesting of price-vested units and time-based restricted stock units previously granted to the recipient.

(2) Shares held indirectly by Mr. Grant in his capacity as Trustee of a trust for the benefit of one of his minor children.

(3) Beneficially owned by Mr. Grant through Haakon Capital, LLC, an investment company of which he owns one-third. Mr. Grant disclaims beneficial ownership of the shares held by Haakon Capital, LLC, except to the extent of his pecuniary interest therein.

(4) Represents restricted stock units of SelectQuote, Inc. (the "Company") granted to Mr. Grant under the Company's 2020 Omnibus Incentive Plan (the "Plan").

(5) Each restricted stock unit represents a contingent right to receive one share of the Company's common stock, par value $0.01 per share.

(6) The restricted stock units vest ratably in four annual installments commencing on the one-year anniversary of the grant date, subject to the recipient's continued employment with the Company through the applicable vesting date.

(7) The restricted stock units vest ratably in three annual installments commencing on the one-year anniversary of the grant date, subject to the recipient's continued employment with the Company through the applicable vesting date.

(8) The restricted stock units vest ratably in three annual installments commencing on August 1, 2024, subject to the recipient's continued employment with the Company through the applicable vesting date.

(9) The restricted stock units vest ratably in three annual installments commencing on August 1, 2025, subject to the recipient's continued employment with the Company through the applicable vesting date.

(10) Represents price-vested restricted stock units of the Company ("PVUs") granted to the recipient pursuant to the Plan.

(11) Each PVU represents the contingent right to receive one share of the Company's common stock, par value $0.01 per share, upon the Company's common stock reaching certain predetermined average trading prices, subject to applicable vesting conditions.

(12) The PVUs are eligible to vest in three ratable annual installments commencing on the one-year anniversary of the grant date, subject to the recipient's continued employment with the Company through the applicable vesting date. Subject to this vesting schedule, one-fourth of the total number of PVUs granted will vest, if at all, upon the 60-day average closing price of the Company's common stock reaching each of $4.00, $7.50, $10.00, and $12.50 during the five-year performance period. The number of PVUs reported on this line reflects the portion of the total PVU award that vested on the transaction date following the achievement of the $4.00 price hurdle.

(13) The PVUs are eligible to vest in three ratable annual installments commencing on August 1, 2024, subject to the recipient's continued employment with the Company through the applicable vesting date. Subject to this vesting schedule, one-fourth of the total number of PVUs granted will vest, if at all, upon the 60-day average closing price of the Company's common stock exceeding each of $2.50, $5.00, $7.50, and $10.00 during the five-year performance period. The number of PVUs reported on this line reflects the portion of the total PVU award that vested on the transaction date following the achievement of the $2.50 price hurdle.

(14) The PVUs are eligible to vest in three ratable annual installments commencing on August 1, 2025, subject to the recipient's continued employment with the Company through the applicable vesting date. Subject to this vesting schedule, one-third of the total number of PVUs granted will vest, if at all, upon the 60-day average closing price of the Company's common stock exceeding each of $3.13, $6.00, and $9.00 during the five-year performance period. The number of PVUs reported on this line reflects the portion of the total PVU award that vested on the transaction date following the achievement of the $3.13 price hurdle.

(15) The PVUs are eligible to vest in three ratable annual installments commencing on the one-year anniversary of the grant date, subject to the recipient's continued employment with the Company through the applicable vesting date. Subject to this vesting schedule, one-third of the total number of PVUs granted will vest, if at all, upon the 60-day average closing price of the Company's common stock exceeding each of $2.50, $4.00, and $6.00 during the five-year performance period.

**Signature:** /s/ Daniel A. Boulware, Attorney-in-Fact  
**Date:** 2025-08-05

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**